SINGNAD GUGGULU
Original price was: Rs.105.00.Rs.103.00Current price is: Rs.103.00.
CHACHAN SINGNAD GUGGULU BY DINDAYAL AYURVED BHAWAN
Singnad Guggulu Tablet is an ayurvedic medicine mainly used for joint pains, swelling, stiffness and inflammation associated with gout and rheumatoid arthritis. In addition, it is also helpful in the management of skin diseases, abdominal disorders and Vata Disorders (mainly paralysis). It has purgative action, which helps in detoxification and promotes elimination of toxins.
Key Benefits:
- Provides relief from joint pain and swelling
- It helps in management of skin disease
- Helps in management of skin diseases, abdominal disorders and vata disorders
- It has purgative action, which helps in detoxification and increases the toxin elimination
Out of stock
Description
CHACHAN SINGNAD GUGGULU BY DINDAYAL AYURVED BHAWAN
Singnad Guggulu Tablet is an ayurvedic medicine mainly used for joint pains, swelling, stiffness and inflammation associated with gout and rheumatoid arthritis. In addition, it is also helpful in the management of skin diseases, abdominal disorders and Vata Disorders (mainly paralysis). It has purgative action, which helps in detoxification and promotes elimination of toxins.
Key Benefits:
- Provides relief from joint pain and swelling
- It helps in management of skin disease
- Helps in management of skin diseases, abdominal disorders and vata disorders
- It has purgative action, which helps in detoxification and increases the toxin elimination
Directions for use:
- Take one or two or as directed by physician
Safety Information:
- Read the label carefully before use
- Do not exceed the recommended dose
- Keep out of the reach of children
- Store in a cool dry place away from sunlight and heat
Additional information
| Weight | 50 kg |
|---|---|
| Dimensions | 5 × 5 × 6 cm |
| Size | 100 Tab, 2000 Tab, 40 TAB, 400 Tab |
Only logged in customers who have purchased this product may leave a review.
General Inquiries
There are no inquiries yet.

Reviews
There are no reviews yet.